154
Views
18
CrossRef citations to date
0
Altmetric
Miscellaneous

Successful treatment of Sjogren's syndrome with rituximab

, &
Pages 323-325 | Received 05 Aug 2005, Accepted 11 Nov 2005, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Pilar Brito-Zerón, Antoni Sisó-Almirall, Albert Bové, Belchin A Kostov & Manuel Ramos-Casals. (2013) Primary Sjögren syndrome: an update on current pharmacotherapy options and future directions. Expert Opinion on Pharmacotherapy 14:3, pages 279-289.
Read now

Articles from other publishers (17)

Eva Rath, Jochen Zwerina, Bastian Oppl & Valerie Nell-Duxneuner. (2015) Efficacy and safety of rituximab in rheumatic diseasesWirksamkeit und Sicherheit von Rituximab bei rheumatischen Erkrankungen. Wiener Medizinische Wochenschrift 165:1-2, pages 28-35.
Crossref
F. Perosa, M. Prete, V. Racanelli & F. Dammacco. (2010) CD20‐depleting therapy in autoimmune diseases: from basic research to the clinic. Journal of Internal Medicine 267:3, pages 260-277.
Crossref
Thomas Dörner, David Isenberg, David Jayne, Heinz Wiendl, Detlef Zillikens & Gerd Burmester. (2009) Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis. Autoimmunity Reviews 9:2, pages 82-89.
Crossref
Saugar Maripuri, Joseph P. Grande, Thomas G. Osborn, Fernando C. Fervenza, Eric L. Matteson, James V. Donadio & Marie C. Hogan. (2009) Renal Involvement in Primary Sjögren's Syndrome. Clinical Journal of the American Society of Nephrology 4:9, pages 1423-1431.
Crossref
Khaled M. Musallam, Thurayya Arayssi, Ali T. Taher, Nadim Kanj & Imad Uthman. (2008) The use of biological therapy in refractory rheumatic diseases other than rheumatoid arthritis: experience at a tertiary care center in Lebanon. Rheumatology International 29:10, pages 1255-1257.
Crossref
M. Morcillo Valle. (2009) Síndrome de Sjögren. Medicine - Programa de Formación Médica Continuada Acreditado 10:29, pages 1942-1948.
Crossref
K. Isaksen, R. Jonsson & R. Omdal. (2008) Anti-CD20 treatment in Primary Sjögren’s Syndrome. Scandinavian Journal of Immunology 68:6, pages 554-564.
Crossref
Zahi Touma, Thurayya Arayssi, Lina Kibbi & Abdel Fattah Masri. (2008) Efficacité du rituximab dans le traitement d’une dermatomyosite avec atteinte cardiaque. Revue du Rhumatisme 75:5, pages 471-474.
Crossref
Zahi Touma, Thurayya Arayssi, Lina Kibbi & Abdel Fattah Masri. (2008) Successful treatment of cardiac involvement in dermatomyositis with rituximab. Joint Bone Spine 75:3, pages 334-337.
Crossref
M. Gwosdz, A. Körber, U. Hillen & J. Dissemond. (2007) Vaskulitische Ulcera cruris bei primärem Sjögren-SyndromVasculitic leg ulcers in primary Sjogren syndrome. Der Hautarzt 59:5, pages 404-408.
Crossref
S.A. Mathews, B.T. Kurien & R.H. Scofield. (2008) Oral Manifestations of Sjögren’s Syndrome. Journal of Dental Research 87:4, pages 308-318.
Crossref
Aikaterini Thanou-Stavraki & Judith A. James. (2008) Primary Sjogren’s Syndrome: Current and Prospective Therapies. Seminars in Arthritis and Rheumatism 37:5, pages 273-292.
Crossref
Hèctor Corominas, Ramon Fíguls & Manel Riera. (2008) Síndrome de Sjögren. Reumatología Clínica 4, pages 22-27.
Crossref
D. G. Arkfeld. (2007) The potential utility of B cell-directed biologic therapy in autoimmune diseases. Rheumatology International 28:3, pages 205-215.
Crossref
Patricia K.A. Mongini. (2007) COX-2 expression in B lymphocytes: Links to vaccines, inflammation and malignancy. Clinical Immunology 125:2, pages 117-119.
Crossref
Ikuko Hayakawa, Thomas F. Tedder & Yuan Zhuang. (2007) B-lymphocyte depletion ameliorates Sjögren's syndrome in Id3 knockout mice. Immunology 122:1, pages 73-79.
Crossref
R. John Looney. (2007) Will targeting B cells be the answer for Sjögren's syndrome?. Arthritis & Rheumatism 56:5, pages 1371-1377.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.